top of page
  • Writer's pictureD. Brit

FDA Approves Antiviral Remdesivir for Covid-19 Treatment

What Happened:

  • On Thursday, US regulators approved the antiviral Remdesivir to help treat Covid-19 patients. Remdesivir, which is given to hospitalized patients via an IV, is the first drug to gain full FDA approval for Covid-19 treatment.

  • According to a large study conducted by the National Institute of Health, the drug, developed by Gilead Sciences, helps reduce the recovery time for many patients by up to 5 days; thereby reducing the 15 day average recovery time to about 10 days.

  • Remdesivir has been authorized for use on an emergency basis since the spring.

  • The drug works by making it more difficult for the virus to make copies of itself.

  • It is important to note, that while Remdesivir can help reduce the recovery time, the drug itself does not improve the survival odds of hospitalized patients, nor is it a vaccine.

Photo Source: Pixabay

#newspura #justfactsnoopinions #remdesivir #gileadsciences #covid19 #pandemic #coronavirus #covid19treatment

9 views0 comments
bottom of page